在牛皮中结:当前的景观和前景
Dinesh Kumar1, Debayan Sil1, Balak Das Kurmi2
1Department of Quality Assurance, ISF College of Pharmacy, Moga, Punjab, 142001, India.
Recent advances in inflammation & allergy drug discovery
|July 31, 2025
概括
牛皮的治疗是通过PDE4抑制剂Apremilast进行的. 纳米技术增强了Apremilast的输送,提高了斑块性牛皮和牛皮性关节炎的疗效.
科学领域:
- 皮肤病学和免疫学
- 药理学和药物输送
- 纳米技术在医学中的应用
背景情况:
- 牛皮是一种流行的免疫媒介性皮肤疾病,影响全球数百万人.
- 它呈现出各种形式,并与诸如牛皮关节炎等疾病有关.
- 阿普雷米拉斯特是一种固酶-4 (PDE4) 抑制剂,是FDA批准的口服治疗.
研究的目的:
- 为了审查牛皮的机制.
- 讨论Apremilast的特性,临床疗效和药理动力学.
- 探索纳米载体系统在增强用于治疗牛皮的Apremilast输送中的作用.
主要方法:
- 审查关于牛皮,Apremilast和纳米药物输送系统的现有文献.
- 对Apremilast在斑块性牛皮和牛皮性关节炎中的随机对照试验的分析.
- 对以纳米技术为基础的配方 (乙体,阴体,脂质体,纳米结构脂质载体) 对Apremilast的检查.
主要成果:
- 阿普雷米拉斯特有效治疗中度至重度的斑块性牛皮和牛皮性关节炎,与传统药物相比,其安全性较好.
- 纳米技术提供了增强的溶解性和针对性释放的Apremilast.
- 新型纳米载体配方显示出改善牛皮治疗结果的潜力.
结论:
- 阿普雷米拉斯特在牛皮管理方面取得了重大进展.
- 基于纳米技术的药物输送系统是优化Apremilast治疗潜力的有希望的方法.
- 对纳米载体修饰的进一步研究可能会导致增强的牛皮治疗方法.
关键词:
牛皮是一种病.在最后的早餐之后.循环腺单酸盐 (cAMP) 的使用药物输送系统是药物输送系统.这是一种炎症炎症炎症炎症.纳米载体的纳米载体纳米结构的脂质载体.它是一种固酶-4 (PDE4) 抑制剂.斑块性牛皮病是一个病.牛皮关节炎 牛皮关节炎更多相关视频
相关概念视频
01:20Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
01:19Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464